The diabetic foot syndrome or disease (DFD) includes several pathologies, mainly diabetic peripheral neuropathy and peripheral arterial disease which result in foot ulceration. Diabetic foot ulceration may ultimately lead to amputation, especially when wound infection or osteomyelitis are involved. Diabetic foot ulcer is defined as a full-thickness wound which is present at a level distal to the ankle in patients with diabetes[1,2]. Special categories like Charcot neuroarthropathy are also included in the DFD. Patients with diabetic foot are also more likely to present with other diabetes-related complications such as nephropathy, retinopathy, ischemic heart disease and cerebrovascular disease.
DFD is a common complication which is multifactorial in nature. A good understanding of its various predisposing risk factors would help in both prevention and treatment of this devastating medical condition. The present review paper attempts to address the major challenges and barriers for a better approach of the DFD.
DFD occurs in all types of diabetes showing higher prevalence among males and in patients more than 60 years old. The burden of DFD is expected to rise in the future, giving that the prevalence of its predisposing factors - mainly the diabetic peripheral neuropathy and peripheral limb ischemia are continually increasing. Epidemiological studies for the DFD incidence and prevalence, present various conduction difficulties mostly related to the diagnostic tests used and the population selection.
The annual incidence of foot ulceration is estimated to be approximately 1%-4%[7,8], and its prevalence ranges from 4% to 10%, whereas, the lifetime risk for the development of a diabetic foot ulcer in patients with diabetes ranges from 15% to as high as 25%[7,9].
The presence of foot ulceration is considered to be the main precursor of a lower extremity amputation among patients with diabetes. Apart from the diabetic peripheral neuropathy and the peripheral vascular disease, several other risk factors were identified such as, the limited joint mobility, the foot deformities and any previous ulceration or amputation at the same or contralateral limb. Other risk factors are related to the patient’s general condition including; impaired visual acuity, older age, chronic renal disease, long duration of diabetes & sustained uncontrolled hyperglycemia[11-14].
According to the International Consensus Group on Neuropathy; the diabetic neuropathy is defined as the detection of manifestations of peripheral nerve dysfunction in people with diabetes, after excluding other possible causes of peripheral neuropathy. It is not an uncommon condition; in fact it is one of the most common long term complications of diabetes and the most common form of neuropathy in many parts of the world.
The presence of diabetic peripheral neuropathy, even with trivial trauma, is the initiating factor of the development of foot ulceration in patients with diabetes. It has been reported that the risk for diabetic foot ulceration increases by seven fold in patients with peripheral diabetic neuropathy[16,17]. It is also estimated that 45% to 60% of all ulcerations in patients with diabetes are mainly due to neuropathy, while 45% of the ulcers are due to combined neuropathic and ischemic factors (Figure 1)[12,16,18,19].
Figure 1 A neuropathic ulcer in a patient with severe diabetic peripheral neuropathy.
Distal bilateral symmetrical neuropathy
This form of neuropathy is the commonest presentation among patients with diabetes. It usually starts in the lower limbs while the upper limbs may be also involved too in some cases. It has a progressive course, starting distally and then proceeds proximally as the severity of nerve dysfunction increases. It usually presents in a glove and stocking pattern of abnormal sensations.
The distal symmetrical diabetic neuropathy may present with different clinical symptoms. Patients may describe it as symptoms of unpleasant sensations such as tingling, burning, prickling, electric shocks, lancinating pain, hyperalgesia (exaggerated perception of pain on application of a painful stimulus) or even allodynia (contact pain or pain perception due to a non-painful stimulus). Some patients may report abnormal cold or hot feelings in their feet or persistent painful cramp-like sensations even at rest. It is worth mentioning that most of the patients may be completely asymptomatic and unaware of having peripheral neuropathy. Patients may present with diabetic foot ulceration even without any preceding neuropathic complaints.
Although the sensory nerve fibers are the most commonly affected fibers, motor nerve fibers are sometimes affected too, leading to muscle denervation. During the early course of the disease, the muscle power is preserved except mild muscle weakness in the toe extensors. As the disease progresses muscle weakness becomes more generalized affecting small muscles in both feet and hands. This muscle wasting can result in altering the normal foot dynamics and pressure distribution. Wasting and atrophy of small muscles in the foot lead to loss of joint stability and the development of foot deformities. Foot deformities may take several forms such as equinus or varus deformity, hammer toes, cocked-up toes and flat foot changes. These changes lead to pressure distribution disturbance, increased shear stress and friction, ultimately leading in foot ulceration[22-25]. Diabetic peripheral neuropathy is also characterized by the loss of the deep sensation, such as vibration perception and proprioception which in severe cases might lead to sensory ataxia and a positive Romberg’s sign. Deep tendon reflexes are usually impaired or lost starting with ankle reflex and progressing proximally to the knee reflex.
Additionally diabetic autonomic neuropathy may result in sudomotor dysfunction leading to abnormal sweating and dry skin with cracking and fissuring facilitating the bacterial infection of the foot. Autonomic neuropathy is also associated with thermoregulatory dysfunction and abnormal tissue perfusion. Autonomic neuropathy is also in many cases associated with an unexplained foot edema which is resistant to diuretics. This edema results from shunt opening and hyperkinetic circulation, further adding to the risk of foot ulceration.
Diagnosis of the diabetic peripheral neuropathy
Diabetic peripheral neuropathy is diagnosed through careful patient history review and physical examination of the feet. Using the combination of patient’s neuropathic symptoms, clinical signs and electrodiagnostic tests would be the best predictor for diabetic peripheral neuropathy.
Symptom scores: Various verbal descriptive scales and simple visual analog scales are used in clinical practice to assess and follow up the neuropathic symptoms in response to treatment[29,30]. Symptom scores are used for the evaluation of painful diabetic neuropathy. The most widely used ones are: The Neuropathy Symptom Score (NSS), which is widely used in clinical practice has shown high validity and sensitivity[31-34]. Several other adaptations are also available such as the Neuropathy Symptom Profile, the modified NSS scores of Veves and Young, the Michigan Neuropathy Screening Instrument, and Diabetic NSS[17,35-38].
Semmes-Weinstein monofilament: Semmes-Weinstein monofilament is a widely used tool for the assessment of the diabetic peripheral neuropath in every day clinical practice[39,40]. It assesses the protective ability (evaluates A-beta fibers, determining the patient’s threshold for light touch and pressure) of the foot through the application of gentle pressure to the handle until the nylon filament is buckled for 2 s. Many different sizes of filaments are available with the 10-g pressure monofilament (5.07 monofilament) to be the most commonly used for pressure sensation evaluation. Around 90% of the patients with insensate diabetic foot could be identified on testing four planter sites (great toe and the base of first, third and fifth metatarsals). Monofilament test has shown a sensitivity of (66%-91%) in detection of diabetic patients at high risk for foot ulceration in several studies[18,42,43]. The monofilament test is a quick and painless method, easily acceptable from the patient, easy to administer by the physicians, portable and inexpensive.
Vibration perception: The impairment of vibration perception is usually one of the earliest signs of peripheral diabetic neuropathy. Vibration assessment evaluates the large diameter fibers (A-beta fibers). There are several ways for examining the vibration perception threshold (VPT), including: (1) 128 Hz tuning fork: It assesses the vibration perception through application on distal bony prominences of the great toe bilaterally and proceeds proximally on other bony prominences such as the medial malleolus and tibial tuberosity if impairment is noted. Tuning fork gives around 53% sensitivity and there is evidence suggesting that compared to the monofilament test, tuning fork is less predictive for development of foot ulceration; (2) graduated rydel-seiffer tuning fork: The graduated tuning fork depends on optical visual illusion. The fork has 0-8 graded scale, where the examiner can detect the point of vibration impairment or disappearance. Application of the graduated tuning fork detects the presence of vibration perception impairment and the intensity of this impairment. The reduction of vibration perception to less than 4/8 was present in 95% of diabetic foot ulcerations due to peripheral neuropathy[44,45]; (3) neurothesiometer; and (4) biothesiometer.
The neurothesiometer and biothesiometer are electronic devices. They depend on sending vibrations of various strengths through a probe applied to the bony prominence of the great toe. The vibrations are measured in volts per micrometer. As the VPT of the patient increases, the risk for diabetic foot ulceration due to neuropathy increases. A vibration threshold of more than 25 V has been reported to have a sensitivity of 83%. The risk of ulceration in the group of patients with sensitivity between 25 and 33 V was increased by eight times compared to twenty-fold increase associated with values of more than 42 V[46,47].
Nerve conduction studies: Nerve electrophysiologic conduction studies are not routinely used in clinical practice for diagnosis of diabetic neuropathy. They are objective, non-invasive, highly reliable parametric measures which are useful in monitoring the progression of diabetic peripheral neuropathy especially in asymptomatic patients. They are also extremely useful in atypical presentations of neuropathy and in superimposed forms of mononeuropathies. Electromyography and nerve conduction studies such as NCV and F waves can detect the type of nerve injury, extend, symmetry and severity of the lesion.
Other methods of assessment: (1) Nerve biopsy: It is an invasive procedure used for diagnosis of peripheral neuropathy and atypical presentations in patients with diabetes, usually using sural nerve biopsy. Nerve biopsy has many complications such as postoperative pain at the site of nerve biopsy, parasthesia, allodynia and sensory disturbances at the sites of nerve distribution especially in patients with diabetes. Assessment of efficacy of treatment and disease progression can be determined depending on morphological parameters such as axonal atrophy, density of myelinated fibres and axo-glial dysjunction[53,54]; (2) Skin biopsy: It is another less invasive technique alternative to nerve biopsy for studying small nerve fibers using a 3-mm skin biopsy in clinical studies. Several neuronal markers are used to immunostain skin nerves, such asneurone-specific enolase and somatostatin. The best cytoplasmic axonal marker has been proposed is the protein gene product-9.5. Formalin-fixed frozen sections are used in clinical research to visualize and assess the density of intraepidermal nerve fibers[56,57].
Is there a role for validated scores
Validated scores are available in order to standardize the clinical assessment for the severity of symptoms and the grade of neuropathic impairment. The validated scores include; Neuropathy Disability Score for neuropathic deficits (impairments), NSS for neuropathic symptoms and the Michigan Neuropathy Screening Instrument. According to the Neuropathy Disability Score and the NSS, minimum criteria required for the clinical diagnosis of neuropathy are: (1) the presence of moderate signs of neuropathy in the presence or absence of symptoms; (2) the detection of mild signs in the presence of moderate symptoms.
PERIPHERAL ARTERIAL DISEASE
Peripheral arterial disease (PAD) is one of the multifactorial causes leading to the diabetic foot disease. The presence of PAD alters the normal body response to foot ulcerations and leads to persistent non-healing foot ulcers, when there is an increased need for blood supply. PAD leads to progression of infection, increases tissue break down and insufficient delivery of oxygen, nutrition and antibiotics. All these factors further contribute to a potential foot amputation.
PAD shows higher prevalence among patients with diabetes than the general population. PAD among patients with diabetes is characterized by onset at an earlier age, increased severity, a more rapid progression and equal sex distribution. About 20% of patients having symptomatic PAD had diabetes as reported by the Framingham Heart Study. In patients with diabetes, the risk of PAD is increased by advanced age, duration of diabetes, uncontrolled hyperglycemia and the association with diabetic peripheral neuropathy. The presence of diabetes is mostly associated with below knee PAD such as tibial, popliteal and femoral arterial affection, in contrast to more proximal PAD in the aorto-iliofemoral vessels associated with other risk factors such as hypertension and smoking.
PAD is characterized by the presence of intermittent claudication, which is defined as cramping or aching pains usually in the calf muscles, but can also be present in thighs or the buttocks. Intermittent claudication is aggravated by walking exercise that it forces the patient to stop walking and relieved by rest. In severe cases of PAD, pain may be present even at rest, limb may show gangrenous changes, tissue loss; which is known as critical limb ischemia (Figure 2).
Figure 2 Gangrene in a patient with type 2 diabetes and severe peripheral arterial disease.
Diagnosis of PAD
The ankle-brachial index: The ankle-brachial index (ABI) is a simple bed-side screening tool for the presence of PAD. PAD simply depends on the calculation of the ratio between the systolic pressure of the ankle arteries and the systolic pressure at the brachial arteries. ABI is an inexpensive method that can assess the severity of PAD as it usually correlates with the patient’s reported symptoms and functional status. The normal range is of ABI is between 0.9-1.3, falsely elevated values of ABI can result in cases of calcified, non-compressible arteries. Thus the ABI method may lead to underestimation of the severity of the disease in patients with diabetes.
The toe-brachial index: The toe-brachial index is calculated similar to the ABI, where the systolic pressure is measured using a small cuff and a Doppler probe. Measuring the toe-brachial index is helpful especially in cases of ABI values more than 1.30, as the small arteries of the lower limb are less likely to be calcified. A toe-brachial index lower than 0.70 is diagnostic for PAD.
Segmental limb pressure assessment and pulse volume recordings: The technique depends on plethysmographic cuffs situated over the brachial arteries and different points on the lower limb. The extent and location of PAD can be detected from segmental systolic pressure assessment using a Doppler probe.
Ultrasound velocity spectroscopy and imaging: The normal arterial Doppler velocity shows a triphasic signal. When an arterial obstruction is present proximal to the probe, there is loss of the normal reversed flow component on transforming the waveform associated with decreased amplitude, attenuation of all parts of the spectrum and delayed upstroke.
Duplex ultrasound depends on combining the B-mode and the pulsed Doppler ultrasound to assess arterial flow and localized velocity information at stenotic sites. Duplex ultrasonography is widely used nowadays detecting with high sensitivity and specificity the arterial patency and extends of obstruction. Duplex ultrasound has certain limitations mainly difficulty in identifying close multiple separate lesions, some difficulty when assessing infrapopliteal, common and external iliac arteries[69,70].
Transcutaneous oximetry and laser - doppler flowmetry: These techniques are used mainly to assess cutaneous blood flow. Cutaneous blood flow is usually normal until late stages of proximal arterial ischemia of the atherosclerotic type, thus, this type of vascular evaluation is not used in every day practice.
Magnetic resonance angiography (MRA)[71,72].
Computed tomographic angiography: CTA is superior to MRA as it can detect the presence of calcification, which is advantageous on planning revascularization strategies. The ACC/AHA guidelines recommend CTA on deciding the revascularization techniques in cases of PAD, offering faster image than MRA.
Contrast angiography: Although it is the gold standard for the diagnosis of PAD, is rarely required as a diagnostic tool due to the risks associated with invasive procedures. Computer-enhanced digital subtraction angiography can be useful in patients who present with localized stenosis so as to minimize the amount of contrast material injected and for better image resolution.
Diabetic foot ulcers.
The presence of diabetic foot ulceration is the main leading risk for amputation in patients with diabetes. Proper assessment and classification of a diabetic foot ulcer is an essential part for the management of the diabetic foot. A prompt and adequate ulcer treatment may lead to foot amputation prevention, preserving the life quality of the patient.
Several classifications have been proposed for the categorization of diabetic foot ulcers. The most important ones are described below.
It is one of the earliest and most widely used classifications. It classifies the diabetic foot ulceration depending on how deep the wound is, includes 6 grades: (1) Grade 0: The skin is intact; (2) Grade 1: Presence of ulcer which is superficial; (3) Grade 2: Presence of ulcer which is deep; (4) Grade 3: Deep ulcer with abscess, bone involvement or osteomyelitis; (5) Grade 4: Gangrene in the forefoot; and (6) Grade 5: Whole foot gangrene.
Wagner-Meggitt classification has shown several disadvantages: (1) cannot address all patterns of diabetic foot ulcerations and infections; (2) the presence of infection is addressed in only one stage, thus, the superficial ulcers if infected or ischemic are not properly categorized in this system; and (3) this system does not properly assess the presence of peripheral ischemia in categorization of foot ulcers.
The university of texas system
It classifies diabetic foot ulcers into 4 grades (0-4) according to their depth, and then stages every grade of them according to the presence or absence of infection and ischemia (A-D).
The University of Texas Classification has been validated and has prognostic advantages as it included both infection and ischemia but showed some difficulty in application in day to day practice.
The SAD classification
This classification grades the diabetic foot ulceration according to five ulcer features (size, depth, sepsis, arteriopathy, and denervation) on a 4-point scale (0-3).
SAD classification differs from the other earlier systems by considering both size of ulcer and the presence of neuropathy. It has been validated by demonstrating differences between baselines variable and clinical outcome. Its major drawback is the complexity in practical use.
The pedis classification
The PEDIS system has been proposed by the International Working Group on the Diabetic Foot. This system grades the wound based on five features: (1) perfusion (arterial blood supply); (2) extent (area of the ulcer); (3) depth of the wound; (4) presence of infection; and (5) sensation.
The Infectious Diseases Society of America guidelines
These guidelines sub classified the infected diabetic foot into three categories: (1) mild: Involvement is restricted to skin and subcutaneous tissues; (2) moderate: Involvement is more extensive or affecting deeper tissues; and (3) Severe: Diabetic foot ulceration is accompanied by systemic signs of infection or metabolic decompensation.
PRINCIPLES OF DIABETIC FOOT ULCERS MANAGEMENT
Debridement of diabetic foot ulcers is an important initial step in the management of the wound. Several benefits can result from proper debridement including the removal of the necrotic and non-viable tissues and keeping a healthy granular wound bed. One should be careful on the assessment of the ulcer if ischemia is suspected. A revascularization intervention may be necessary before a debridement is performed. Debridement is also stimulating the release of growth factors to promote advancing healing edges[77,78]. Various methods are used for wound debridement.
Surgical debridement: It is the gold standard method in diabetic foot ulceration. To obtain optimal results, healthy tissue loss should be minimized, foot function should be preserved, and deformities which can precipitate recurrence of ulcers should be prevented. Surgical debridement is typically done for ulcers with large amount of necrotic and non-viable tissues. Debridement is performed using a scalpel blade with the tip pointed in a 45-degree angle or a tissue nipper to remove all necrotic and non-viable tissues until a bleeding healthy base is obtained.
Enzymatic debridement: Enzymatic debridement is based on the application of topical agents on the ulcer. These agents are usually applied once daily. Their action is based on the necrotic tissue degradation using proteolytic digestive enzymes such as streptokinases, trypsin, papain, fibrinolysin-DNase, collagenase, papain-urea and streptodornase. Data from clinical studies have shown conflicting results about the efficacy of these topical agents, thus, their additional benefits to standard wound care remains unclear. Putting into consideration the need of long time application, as well as, the high cost, their use is usually limited to slowly soften large eschars or debridement of some decubitus ulcerations in sensate limbs. In order to improve efficacy of these agents, a scalpel blade is applied to crosshatch eschars.
Mechanical debridement: Although it is a simple and an inexpensive tool, it can remove both viable and also non-viable tissues leading to pain in sensate foot. The wet gauze dressing is applied to the wound bed and then kept to dry. The necrotic debris embedded in the gauze is mechanically stripped from the wound bed on gauze removal.
Biological debridement (Maggot therapy): Recently the use of Maggot therapy has re-emerged showing benefits in necrotic tissue debridement, decreasing bacterial load and stimulation of wound healing. Several studies showed the efficacy of Maggot therapy[82-84].
Other modalities: Ongoing research is evaluating other methods such as low energy ultrasound mist for the debridement of diabetic foot ulcers.
The pressure offloading relieves abnormal pressure applied to the ulcer promoting the wound healing. Several methods have been applied for offloading including; total contact casting (TCC), short leg walkers, half shoes and felted foam dressings. TCC is based on a well-molded plaster cast, resulting in equal pressure distribution to the whole lower limb. This method is very effective with a good wound healing rate when applied properly and changed at least weekly. Although it is an effective method it has significant disadvantages which may limit their use and the choice of other alternatives. Disadvantages of TCC include; time and skill required to be applied properly, secondary skin irritation and ulceration resulting from the cast applied, and impossible daily assessment of the wound[85,86].
Other alternative to TCC is the Scotch-cast boot with a cast sandal to increase mobility and at the same time ensure ulcer relief from pressure. Commercial devices such as the short leg walker and half shoe are readily available, they are preferred by the patients with a better acceptance, simple, easy to apply and inexpensive. Their major disadvantage is that patients can remove them thus cannot ensure patient’s compliance with less significant pressure relieving results compared to the TCC.
Felted foam dressings allow a customized pressure relief through a felt-foam pad with an opening over the ulceration through which wound assessment and care can be done. The felted foam is used in combination with half-shoe or surgical shoe and when used properly and changed every 10-14 d, has shown more efficacy compared to half-shoe or short walkers alone.
Treatment of infection
The presence of infection is a common finding in diabetic foot ulcers which act as an entry route for pathogens. Infections must be diagnosed and treated promptly and adequately as they may rapidly progress to a limb-threatening condition. Also high levels of bacteria can delay or event prevent wound healing and impede surgical closure of diabetic ulcers.
Diagnosis of diabetic foot ulcer infection: Diagnosis of infection is based initially on clinical signs such as redness, temperature, pain, tenderness, edema and the presence of suspected discharge. On clinical suspicion of infection, properly taken cultures from the wound area may be helpful in proper antibiotic treatment selection. It is important to point out that uninfected ulcers is not necessary to be cultured as the results will only indicate the colonizing flora. The most common pathogens in diabetic foot ulcers are aerobic gram positive cocci and gram negative bacteria. Anaerobic organisms are frequently isolated too. Staphylococcus and streptococci are the most frequently causative agents for non-threatening limb infections while limb-threatening infections are mostly polymicrobial in nature.
The use of antibiotics in infected diabetic foot ulcer should be carefully applied, in order to be assured that the patient will receive the appropriate antibiotic therapy, for an adequate period of time, along with wound debridement and drainage.
Diabetic foot care
To be able to provide an effective plan for diabetic foot syndrome prevention and treatment, a multidisciplinary team approach is required.
This multidisciplinary team approach includes[10,91]: (1) diabetologist/Endocrinologist to optimize the metabolic control for patients with diabetes; (2) diabetes educator and a qualified nurse: To provide special education and assurance; (3) podiatrist who would guide the patient to prevent diabetic foot lesions and provide appropriate treatment; (4) vascular surgeon to assess the vascularity of the lower limbs and provide interventional management whenever required; (5) orthotist: Help in choosing the appropriate foot wear or custom foot wear to allow adequate pressure distribution and thus rapid wound healing; (6) infection disease specialist: For appropriate choice of antibiotics regimen based on culture results; and (7) nutritionist consultation to help in adequate glycemic control, weight loss and also wound healing.
MODERN WOUND CARE MODALITIES
In the recent years, apart from the standard wound care, new diabetic ulcer treatment modalities have been developed[92,93].
The ideal wound dressing: (1) should be sterile and does not contaminate the ulcer with foreign particles; (2) should be readily available, easy to use and cost effective; (3) should keep a moist environment for adequate wound healing; (4) should be able to absorb excess exudates from the wound; (5) should not adhere to the wound floor, also should be non-allergic and non-toxic; (6) should be able to protect the wound from microorganisms and also provides mechanical protection; and (7) should maintain adequate tissue gaseous exchange and control wound odor.
Wet to dry dressing (simple saline dressing): Wet to dry dressing is included in standard wound care and is considered a method for mechanical debridement, since it presents a good debriding effect in removal of the necrotic tissue and wound preparation. In order to minimize irritation and discomfort, adequate moistening of the dressings with normal saline is done when treating granulating wound tissues to avoid trauma and bleeding.
Local antibacterial agents: Antibacterial agents can be used alone or in combination with other dressings except for dry necrotic ulcers. For effective anaerobic coverage, metronidazole gel is used and maintains a moist environment for wound healing[97,98]. Several antibiotics have effective antibacterial action on topical application such as Neomycin, Gentamycin, and Mupirocin. Silver dressings and polyherbal topical preparations have shown good antibacterial action. For effective antibacterial action against Pseudomonas, other gram-negative bacilli, and beta hemolytic streptococci wound infections Sisomycin and acetic acid can be used. Special precautions should be considered when using povidone iodine solution dressings, iodine has been found to be toxic at high concentrations to bacteria and fungi as well as human cells[100,101].
Tulle dressings: Tulle dressings are used mainly for skin grafts and superficial wounds. They can be safely used in granulating and epithelializing tissues as they are impregnated with paraffin, having low dressing adherence properties. Evidence from several previous studies have shown better and faster re-epithelialization rates compared to dry dressing[102-104].
Hydrogel dressings: Hydrogel dressings are considered the best choice for dry wounds with necrotic eschar. Hydrogels provide fluid and good hydration to dry and slough wounds. Although they are very good at absorbing exudates, they should be avoided in diabetic foot planter ulcers as they may cause maceration of the skin surrounding the wound[105-107].
Polyurethane films: Polyurethane films are transparent films coated with a water-proof adhesive dressing. They provide permeable films allowing diffusion of gases and vapor thus an adequately moist wound environment. They have the advantage of being transparent, thus can monitor the wound progression. They also can be used for low exudates wounds, but they may cause maceration of the skin surrounding the wound.
Polyurethane foam: Polyurethane foam is highly used in diabetic foot ulcers. It can absorb large amounts of exudates in a non-adherent nature thus does not cause wound sloughing or trauma on removal. They maintain moisture environment thus allow proper preparation of wound bed and promotes better wound healing.
Alginate dressings: Two forms of alginate dressings are available; calcium alginate and calcium sodium alginate. Alginate dressings can absorb large amounts of exudates up to 20 times their weight as shown by several clinical studies.
Honey-impregnated dressings: The anti-inflammatory and anti-microbial actions have been shown in vitro studies but further studies are required to support strong evidence in vivo[111,112].
Growth factors have shown promising results in diabetic ulcer healing. Growth factors stimulate angiogenesis, cellular proliferation and migration, together with promoting enzymatic production. Several growth factors have been studied including; platelet-derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor (TGF)-β, TGF-α and insulin-like growth factor…, etc.. A recombinant human (rh)-PDGF dressing is available for diabetic foot lesions when added to conventional. EGF in the form of local injections of rh-EGF showed favorable results in neuropathic vs ischemic ulceration.
The Food and Drug Administration (FDA) announced some warnings regarding the use of a recombinant human platelet-derived growth factor, which contains becaplermin. In both clinical studies and post marketing users, becaplermin was associated with malignancies distant from the application site. Also increased mortality rate from systemic malignancies was reported on using 3 or more tubes of becaplermin gel. Topical enzymes: Several prepared ointments containing enzymes such as fibrinolysin, collagenase or papain have been used in enzymatic debridement of the sloughy tissues and promoting granulation tissue formation. Papain-urea has shown better enzymatic debridement effect when compared to collagenase.
Vacuum-assisted closure: Vacuum-assisted devices have shown efficacy in exudates removal and edema reduction. Ideally a pressure of 125 mmHg can generate a negative topical pressure over the diabetic foot wound. It has the advantage of leaving the wound surface moist. It has several limitations; it is contraindicated in cases of osteomyelitis, ischemia, deep tissues exposure such as tendons, bones and blood vessels, presence of necrotic tissues and fistulas. Vacuum-assisted devices are also effective in promoting closure and wound healing in patients with treated infections and treated osteomyelitis[118,119].
Hyperbaric oxygen therapy, Do we have evidence A systemic treatment where oxygen is breathed but at a higher pressure than the local atmospheric pressure. HBOT has shown increased healing rates of diabetic foot ulcers, however it still controversial whether it can be used as adjuvant treatment or not. Hyperbaric oxygen therapy (HBOT) have the advantage of reduction of tissue hypoxia, edema, increase angiogenesis and erythrocytes deformability, antimicrobial effects and increase fibroblastic activity[122-124]. HBOT is approved as an adjunctive treatment to be used in chronic non-healing ulcers by the Undersea and Hyperbaric Medical Society. The European Committee for Hyperbaric Medicine has set a type 2 recommendation for the use of HBOT in the management of diabetic foot ulcers including patients with ischemic wounds without a surgically treatable arterial lesion or as a complement after vascular surgery, in presence of non-healing wounds.
The role of stem cell therapy in PAD: It is worth mentioning that our skeletal muscles have a regenerative capacity as the have multipotentaial and progenitor cells. In cases of critical limb peripheral arterial disease, the transplantation of progenitor cells- derived from bone marrow- has beneficial effects on angiogenesis and ulcer healing as shown in phase I and II studies. The role therapeutic angiogenesis is a promising and a safe method for management of PAD and limb salvage.